Improving sleep for patients with restless legs syndrome. Part II: meta-analysis of vibration therapy and drugs approved by the FDA for treatment of restless legs syndrome

References

• Willis T. Instructions for Curing the Watching Evil in The London Practice of Physick. London, UK: Bassett and Crooke; 1685.
   Google Scholar
• Clark MM. Restless legs syndrome. J Am Board Fam Pract. 2001;14: 368–374.
   PubMedGoogle Scholar
• Konofal E, Karroum E, Montplaisir J, Derenne JP, Arnulf I. Two early descriptions of restless legs syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898). Sleep Med. 2009;10:586–591.
   PubMed Web of Science ®Google Scholar
• American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd ed. Westchester, NY: American Academy of Sleep Medicine; 2005.
   Google Scholar
• Walters AS. Towards a better definition of the restless legs syndrome. Mov Disord. 1995;10:634–642.
   PubMed Web of Science ®Google Scholar
• Yoakum RH. Restless Legs Syndrome Relief and Hope for Sleepless Victims of a Hidden Epidemic. New York, NY: Fireside; 2006.
   Google Scholar
• Mata IF, Bodkin CL, Adler CH, et al. Genetics of restless legs syndrome. Parkinsonism Relat Disord. 2006;12:1–7.
   PubMed Web of Science ®Google Scholar
• Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 2003;126:1485–1492.
   PubMed Web of Science ®Google Scholar
• Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56:263–265.
   PubMed Web of Science ®Google Scholar
• Barriere G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I. The restless legs syndrome. Prog Neurobiol. 2005;77:139–165.
   PubMed Web of Science ®Google Scholar
• Cervenka S, Palhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017–2028.
   PubMed Web of Science ®Google Scholar
• Buchfuhrer MJ, Wayne HA, Kushida CA. Restless Legs Syndrome: Coping With Your Sleepless Nights. New York, NY: Demos; 2007.
   Google Scholar
• Spiegelhalder K, Feige B, Paul D, et al. Cerebral correlates of muscle tone fluctuations in restless legs syndrome: a pilot study with combined functional magnetic resonance imaging and anterior tibial muscle electromyography. Sleep Med. 2008;9:177–183.
   PubMed Web of Science ®Google Scholar
• Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C, de Weerd A. Pathophysiological concepts of restless legs syndrome. Mov Disord. 2007;22:1451–1456.
   PubMed Web of Science ®Google Scholar
• Lettieri CJ, Eliasson AH. Pneumatic compression devices are an effective therapy for restless legs syndrome: a prospective, randomized, double-blinded, sham-controlled trial. Chest. 2009;135:74–80.
   PubMed Web of Science ®Google Scholar
• Mitchell UH, Myrer JW, Johnson AW, Hilton SC. Restless legs syndrome and near-infrared light: an alternative treatment option. Physiother Theory Pract. 2011;27:345–351.
   PubMedGoogle Scholar
• Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol. 2010;6:337–346.
   PubMed Web of Science ®Google Scholar
• Earley CJ, Connor JR, Beard JL, Clardy SL, Allen RP. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep. 2005;28:1069–1075.
   PubMed Web of Science ®Google Scholar
• Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res. 2005;14:43–47.
   PubMed Web of Science ®Google Scholar
• Earley CJ, Horska A, Mohamed MA, Barker PB, Beard JL, Allen RP. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med. 2009;10: 206–211.
   PubMed Web of Science ®Google Scholar
• Kanter AH. The effect of sclerotherapy on restless legs syndrome. Dermatol Surg. 1995;21:328–332.
   PubMed Web of Science ®Google Scholar
• Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med. 2006;19:487–493.
   PubMed Web of Science ®Google Scholar
• Eliasson AH, Lettieri CJ. Sequential compression devices for treatment of restless legs syndrome. Medicine (Baltimore). 2007;86: 317–323.
   PubMed Web of Science ®Google Scholar
• Mitchell UH, Johnson AW, Myrer B. Comparison of two infrared devices in their effectiveness in reducing symptoms associated with RLS. Physiother Theory Pract. 2011;27:352–359.
   PubMedGoogle Scholar
• Cui Y, Wang Y, Liu Z. Acupuncture for restless legs syndrome. Cochrane Database Syst Rev. 2008;4:CD006457.
   Web of Science ®Google Scholar
• Longe SE, Wise R, Bantick S, et al. Counter-stimulatory effects on pain perception and processing are significantly altered by attention: an fMRI study. Neuroreport. 2001;12:2021–2025.
   PubMed Web of Science ®Google Scholar
• Burbank F, Buchfuhrer MJ, Kopjar B. Sleep improvement for restless legs syndrome (RLS) patients. Part I. Pooled analysis of two prospective, double-blind, sham-controlled, multi-center, randomized clinical studies of the effects of vibrating pads on RSL symptoms. Journal of Parkinsonism and Restless Legs Syndrome. 2013;3:1–10.
   Google Scholar
• Blitz B, Dinnerstein AJ, Lowenthal M. Attenuation of experimental pain by tactile stimulation effect of vibration at different levels of noxious stimulus intensity. Percept Mot Skills. 1964;19:311–316.
   PubMed Web of Science ®Google Scholar
• Talati R, Phung OJ, Mather J, Coleman CI. Effect of non-ergot dopamine agonists on health-related quality of life of patients with restless legs syndrome. Ann Pharmacother. 2009;43:813–821.
   PubMed Web of Science ®Google Scholar
• Trotti LM, Rye DB. Restless legs syndrome. Handb Clin Neurol. 2011;100:661–673.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–e34.
   PubMed Web of Science ®Google Scholar
• Tao KM, Li XQ, Zhou QH, Moher D, Ling CQ, Yu WF. From QUOROM to PRISMA: a survey of high-impact medical journals’ instructions to authors and a review of systematic reviews in anesthesia literature. PLoS One. 2011;6:e27611.
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700.
   PubMed Web of Science ®Google Scholar
• Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JEJ, editors. Measuring Functioning and Well-Being; The Medical Outcomes Study Approach, 4th ed. London, UK: Duke University Press; 1998.
   Google Scholar
• Borenstein M, Hedges LV, Higgins J, Rothstein H. Introduction to Meta-Analysis. West Sussex, UK: John Wiley and Sons Ltd; 2009.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, editors. Cochrane Handbook for Systemic Reviews of Interventions: Cochrane Book Series. Chichester, UK: John Wiley & Sons; 2008.
   Google Scholar
• Allen RP, Kosinski M, Hill-Zabala CE, Calloway MO. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep). Sleep Med. 2009;10:531–539.
   PubMed Web of Science ®Google Scholar
• Abetz L, Arbuckle R, Allen RP, Mavraki E, Kirsch J. The reliability, validity and responsiveness of the Restless Legs Syndrome Quality of Life questionnaire (RLSQoL) in a trial population. Health Qual Life Outcomes. 2005;3:79.
   PubMedGoogle Scholar
• Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med. 2005;6: 41–44.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748.
   PubMed Web of Science ®Google Scholar
• Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338:bll47.
   Google Scholar
• Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord. 2004;19:1414–1423.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry. 2004;75: 92–97.
   PubMed Web of Science ®Google Scholar
• Kushida CA, Becker PM, Ellenbogen AL, Canafax DM, Barrett RW Randomized, double-blind, placebo-controlled study of XP13512/ GSK1838262 in patients with RLS. Neurology. 2009;72:439–446.
   PubMed Web of Science ®Google Scholar
• Ferini-Strambi L, Aarskog D, Partinen M, et al. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial. Sleep Med. 2008;9:874–881.
   PubMed Web of Science ®Google Scholar
• Benes H, Mattern W, Peglau I, et al. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study. J Neurol. 2011;258: 1046–1054.
   PubMed Web of Science ®Google Scholar
• Allen R, Becker PM, Bogan R, et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep. 2004;27:907–914.
   PubMed Web of Science ®Google Scholar
• Lee DO, Ziman RB, Perkins AT, Poceta JS, Walters AS, Barrett RW A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome. J Clin Sleep Med. 2011;7:282–292.
   PubMed Web of Science ®Google Scholar
• Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006;81:17–27.
   PubMed Web of Science ®Google Scholar
• Kushida CA, Geyer J, Tolson JM, Asgharian A. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome. Clin Neuropharmacol. 2008;31: 281–286.
   PubMed Web of Science ®Google Scholar
• Oertel WH, Benes H, Garcia-Borreguero D, et al. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study. Sleep Med. 2010;11:848–856.
   PubMed Web of Science ®Google Scholar
• Hening WA, Allen RP, Ondo WG, et al. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010;25:1675–1683.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Benes H, Poewe W, et al. Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2008;7:595–604.
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. Results summary for ROR104836. Available from: http://www.gsk-clinicalstudyregister.com/result_detail. jsp;jsessionid=4E9BEA7633869AF24A2836793FCAB8ED?prot ocolId=ROR104836&studyId=B6AA2828–2901–48C5-A084–823 ABA244376&compound=ropinirole. Accessed February 21, 2012.
   Google Scholar
• Allen RP, Kushida CA, Atkinson MJ. Factor analysis of the International Restless Legs Syndrome Study Group’s scale for restless legs severity. Sleep Med. 2003;4:133–135.
   PubMed Web of Science ®Google Scholar
• Sensory Medical. NCT00877916 and NCT01145651 trial summaries, 2012. Available from: http://www.sensorymedical.com. Accessed March 29, 2012.
   Google Scholar
• Abetz L, Arbuckle R, Allen RP, et al. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting. Sleep Med. 2006;7:340–349.
   PubMed Web of Science ®Google Scholar
• Mirapex product insert. Ingelheim, Germany: Boehringer Ingelheim; 2011. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2011/020667s025lbl.pdf. Accessed December 30, 2011.
   Google Scholar
• GlaxoSmithKline staff. Requip product insert. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020658s018s020s021lbl.pdf. Accessed December 30, 2011.
   Google Scholar
• GlaxoSmithKline staff. Horizant product insert. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022399s000lbl.pdf. Accessed January 31, 2013.
   Google Scholar
• Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
   Google Scholar
• Hansen RA, Song L, Moore CG, et al. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials. Pharmacotherapy. 2009;29:255–262.
   PubMed Web of Science ®Google Scholar
• Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M. Dopamine agonists for restless legs syndrome. Cochrane Database Syst Rev. 2011;3:CD006009.
   Web of Science ®Google Scholar
• Hogl B, Garcia-Borreguero D, Trenkwalder C, et al. Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome. Sleep Med. 2011;12:351–360.
   PubMed Web of Science ®Google Scholar
• Burbank F Sleep improvement for restless legs syndrome (RLS) patients. Part III: Effects of treatment assignment belief on sleep improvement in RLS patients. A mediation analysis. Journal of Parkinsonism and Restless Legs Syndrome. 2013;3:23–29.
   Google Scholar
• Gardner WJ, Licklider JCR, Weisz AZ. Suppression of pain by sound. Science. 1960;132:32–33.
   PubMed Web of Science ®Google Scholar
• Riley JF, Levine FM. Counterstimulation and pain perception: effects of electrocutaneous vs auditory stimulation upon cold pressor pain. Pain. 1988;35:259–264.
   PubMed Web of Science ®Google Scholar
• Melzack R, Weisz AZ, Sprague LT. Stratagems for controlling pain: contributions of auditory stimulation and suggestion. Exp Neurol. 1963;8:239–247.
   Web of Science ®Google Scholar
• Morosko TE, Simmons FF. The effect of audio-analgesia on pain threshold and pain tolerance. J Dent Res. 1966;45:1608–1617.
   PubMed Web of Science ®Google Scholar
• Reavis KM, Chang JE, Zeng FG. Patterned sound therapy for the treatment of tinnitus. Hear J. 2010;63:21–24.
   Google Scholar
• Margo A, Hemsley DR, Slade PD. The effects of varying auditory input on schizophrenic hallucinations. Br J Psychiatry. 1981;139:122–127.
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 2002;59:1573–1579.
   PubMed Web of Science ®Google Scholar
• Fulda S, Wetter TC. Where dopamine meets opioids: A meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain. 2008;131:902–917.
   PubMed Web of Science ®Google Scholar